TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Tech Stocks

    Is Shopify Inc. the Next Valeant Pharmaceuticals Intl Inc.?

    Shopify Inc. (TSX:SHOP)(NYSE:SHOP) shares plunged following Andrew Left's short thesis on the high-flying Canadian growth king. Should investors dump the…

    Read more »

    The Motley Fool
    Investing

    Is a $5 Billion Debt Reduction for Valeant Pharmaceuticals Intl Inc. Enough?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is well on its way to meeting its goal for debt reduction, but is that…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Value Trap or Opportunity?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to come up as a potential investment option, but is that level of risk…

    Read more »

    The Motley Fool
    Investing

    Healthy Competition: Valeant Pharmaceuticals Intl Inc. vs. Jamieson Wellness Inc.

    Canadians are spending more money on healthcare products as the population ages, but investors need to choose carefully between companies…

    Read more »

    calm, no emotion
    Investing

    Investing in Valeant Pharmaceuticals Intl Inc. Requires Immense Patience

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) got its short-term debt under control, but in a few years, it could become a problem…

    Read more »

    The Motley Fool
    Investing

    These 2 Pharma Giants Are Trading at Steep Discounts

    Healthcare stocks are up 21% since the start of the year, yet Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) and one…

    Read more »

    Investing

    The Top 4 Stocks to Short as Rates Continue to Rise

    With higher interest expenses, companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be the best short sell available.

    Read more »

    calm, no emotion
    Metals and Mining Stocks

    2 Turnaround Stocks Worth Considering

    Cameco Corp. (TSX:CCO)(NYSE:CCJ) has dropped significantly over the past five years, but it is one of several stocks that still…

    Read more »

    The Motley Fool
    Investing

    4 Reasons Valeant Pharmaceuticals Intl Inc. Might Be a Good Investment Today

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is down over 20% in the past month and could present a great buying opportunity.

    Read more »

    The Motley Fool
    Investing

    Better Turnaround Play: Bombardier, Inc. vs. Valeant Pharmaceuticals Intl Inc.

    Bombardier, Inc. (TSX:BBD.B) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are two popular contrarian picks. Here's which one investors should consider…

    Read more »

    The Motley Fool
    Investing

    3 Reasons You Should Be Wary of Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a risky buy during a recovery period and with general headwinds building.

    Read more »

    The Motley Fool
    Investing

    Why an Investment in Valeant Pharmaceuticals Intl Inc. Needs to Be Long Term

    Short-term traders should stay away from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), but long-term investors should take a look.

    Read more »